April 2010
Odin Therapeutics was established April 17th 2010
Odin Therapeutics was established April 17th2010 (org.nr.995378272) and is based upon results from CAST and research from Stefan Krauss’ laboratory.
The focus for the company is on small molecule intervention of the Wnt stem cell pathway for the treatment of colorectal and pancreatic adenocarcinoma.
The technology platform consists of novel small molecules that inhibit the Wnt signaling pathway. The company will develop these new chemical entities for the treatment of colorectal cancer and pancreatic cancer.
The company is currently funded by Medinnova AS and Innovation Norway.
